CETRAXAL

This brand name is authorized in Ecuador, Spain, Finland, Israel, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug CETRAXAL contains one active pharmaceutical ingredient (API):

1 Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE

Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. Read about Ciprofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CETRAXAL Ear drops	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S02AA15	Ciprofloxacin	S Sensory organs → S02 Otologicals → S02A Antiinfectives → S02AA Antiinfectives
Discover more medicines within S02AA15

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 984-MEE-0515
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60883, 62602, 67925
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 382449
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 349407
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8668
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100279921
Country: SG	Health Sciences Authority	Identifier(s): 14596P, 14597P
Country: US	FDA, National Drug Code	Identifier(s): 66992-450